Calcium homeostasis in 40 adolescents with beta-thalassemia major: A case-control study of the effects of intramuscular injection of a megadose of cholecalciferol

Pediatric Endocrinology Reviews

Volumn 6, Issue SUPPL. 1, 2008, Pages 149-154

  Soliman, Ashraf ^a   Adel, Ashraf ^a   Wagdy, Magda ^a   Al Ali, Maryam ^a   ElMulla, Naima ^a  

^a HAMAD MEDICAL CORPORATION   (Qatar)

Author keywords

25 Hydroxyvitamin D (25 OH D); Parathyroid hormone (PTH); Thalassemia

Indexed keywords

ALKALINE PHOSPHATASE; CALCIFEDIOL; CALCIUM; COLECALCIFEROL; DEFEROXAMINE MESYLATE; PARATHYROID HORMONE;

ADOLESCENT; ARTICLE; BLOOD TRANSFUSION; CALCIUM BLOOD LEVEL; CALCIUM HOMEOSTASIS; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; HUMAN; HYPOCALCEMIA; HYPOPARATHYROIDISM; HYPOPHOSPHATEMIA; OSTEOPENIA; PREVALENCE; PROSPECTIVE STUDY; THALASSEMIA MAJOR; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY;

ADOLESCENT; ALKALINE PHOSPHATASE; BETA-THALASSEMIA; CALCIUM; CASE-CONTROL STUDIES; CHILD; CHOLECALCIFEROL; HUMANS; INSULIN-LIKE GROWTH FACTOR I; LINEAR MODELS; PARATHYROID HORMONE; PHOSPHATES; PROSPECTIVE STUDIES; VITAMIN D; VITAMIN D DEFICIENCY; YOUNG ADULT;

EID: 58149484998     PISSN: 15654753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Wonke B, Jensen C, Hanslip JJ, Prescott E, Lalloz M, Layton M, Erten S, Tuck S, Agnew JE, Raja K, Davies K, Hoffbrand AV. Genetic and acquired predisposing factors and treatment of osteoporosis in thalassaemia major. J Pediatr Endocrinol Metab 1998;11:795-801
2. Wonke B. Bone disease in b-thalassaemia major. Br J Haematol 1998;103:897-901
3. Mahachoklertwattana P, Sirikulchayanonta V, Chuansumrit A, Karnsombat P, Choubtum L, Sriphrapradang A, Domrongkitchaiporn S, Sirisriro R, Rajatanavin R. Bone histomorphometry in children and adolescents with beta-thalassemia disease: iron-associated focal osteomalacia. J Clin Endocrinol Metab 2003;88:3966-3972
4. Zaino EC, Yeh JK, Aloia J. Defective vitamin D metabolism in thalassemia major. Ann NY Acad Sci 1985;445:127-134
5. Dandoma P, Menon RK, Houlder S, Thomas M, Flynn DM. Serum 1,25 dihydroxyvitamin D and osteocalcin concentrations in thalassemia major. Arch Dis Child 1987;62:474-477
6. De Sanctis V, Vullo C, Bagni B, Chiccoli L. Hypoparathyroidism in b-thalassemia major. Clinical and laboratory observation in 24 patients. Acta Hematol 1992;88:105-108
7. Zafeiriou D, Athanasiou M, Katzos G, Economou M, Kontopoutos E. Hypoparathyroidism and intracranial calcification in b-thalassemia major. J Pediatr 2001;138:411
8. Karimi M, Habibzadeh F, De Sanctis V. Hypoparathyroidism with extensive intracranial calcification in patients with b-thalassemia major. J Pediatr Endocrinol Metab 2003;16:883-886
9. Aloia JF, Ostuni JA, Yeh JK, Zaino EC. Combined vitamin D parathyroid defect in thalassemia major. Arch Intern Med 1982;142:831-832
10. Johnston CC Jr, Miller JZ, Slemenda CW, Reister TK, Hui S, Christian JC, Peacock M. Calcium supplementation and increases in bone mineral density in children. N Eng J Med 1992;327:82-87
11. Cheng S, Lyytikäinen A, Kröger H, Lamberg-Allardt C, Alén M, Koistinen A, Wang QJ, Suuriniemi M, Suominen H, Mahonen A, Nicholson PH, Ivaska KK, Korpela R, Ohlsson C, Väänänen KH, Tylavsky F. Effects of calcium, dairy product, and vitamin D supplementation on bone mass accrual and body composition in 10-12-y-old girls: a 2-y randomized trial. Am J Clin Nutr 2005;82:1115-1126
12. Guillemant J, Taupin P, Le HT, Taright N, Allemandou A, Pérès G, Guillemant S. Vitamin D status during puberty in French healthy male adolescents. Osteoporos Int 1999;10:222-225
13. Outila TA, Karkkainen MU, Lamberg-Allardt CJ. Vitamin D status affects serum parathyrold hormone concentrations during winter in female adolescents: associations with forearm bone mineral density. Am J Clin Nutr 2001;74:206-210
14. Gordon CM, DePeter KC, Feldman HA, Grace E, Emans SJ. Prevalence of vitamin D deficiency among healthy adolescents. Arch Pediatr Adolesc Med 2004;158:531-537
15. Bischoff-Ferrari HA, Dietrich T, Orav EJ, Dawson-Hughes B. Positive association between 25-hydroxy vitamin D levels and bone mineral density: a population-based study of younger and older adults. Am J Med 2004;116:634-639
16. Chiu KC, Chu A, Go VL, Saad MF. Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr 2004;79:820-825
17. Hollis BW. Assessment of vitamin D nutritional and hormonal status: what to measure and how to do it. Calcif Tissue Int 1996;58:4-5
18. Hanley DA, Davison KS. Vitamin D insufficiency in North America. J Nutr 2005;135:332-337
19. Heaney RP, Davies KM, Chen TC, Holick MF, Barger-Lux MJ. Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. J Clin Nutr 2003;77:204-210
20. Clemens TL, Adams JS, Henderson SL, Holick MF. Increased skin pigment reduces the capacity of skin to synthesise vitamin D3. Lancet 1982;1:74-76
21. Norman AW. Sunlight, season, skin pigmentation, vitamin D, and 25-hydroxyvitamin D: integral components of the vitamin D endocrine system. Am J Clin Nutr 1998;67:1108-1110
22. Grover SR, Morley R. Vitamin D deficiency in veiled or dark-skinned pregnant women. Med J Aust 2001;175:251-252
23. El-Sonbaty MR, Abdul-Ghaffar NU. Vitamin D deficiency in veiled Kuwaiti women. Eur J Clin Nutr 1996;50:315-319
24. Dawodu A, Absood G, Patel M, Agarwal U, Ezimokhai M, Abdulrazzaq Y, Khalayli G. Biosocial factors affecting vitamin D status of women of child-bearing age in the United Arab Emirates. J Biosoc Sci 1998;30:431-437
25. Mishal AA. Effects of different dress styles on vitamin D levels in healthy young Jordanian women. Osteoporos Int 2001;12:931-935
26. Sedrani SH, Elidrissy AW, El Arabi KM. Sunlight and vitamin D status in normal Saudi subjects. Am J Clin Nutr 1983;38:129-132
27. Saadi H, Nagelkerke N, Benedict S, Qazaq HS, Zilahi E, Mohamadiyeh MK, Al-Suhaili AI. Predictors and relationships of serum 25 hydroxyvitamin D concentration with bone turnover markers, bone mineral density, and vitamin D receptor genotype in Emirati women. Bone 2006;39:1136-1143
28. Glerup H, Mikkelsen K, Poulsen L, Hass E, Overbeck S, Thomsen J, Charles P, Eriksen EF. Commonly recommended daily intake of vitamin D is not sufficient if sunlight exposure is limited. J Intern Med 2000;247:260-268
29. Harris SS, Dawson-Hughes B, Perrone GA. Plasma 25-hydroxyvitamin D responses of younger and older men to three weeks of supplementation with 1800 IU/day of vitamin D. J Am Coll Nutr 1999;18:470-474
30. Vieth R. Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr 1999;69:842-856
31. Holick MF. Too tittle vitamin D in premenopausal women: why should we care? Am J Clin Nutr 2002;76:3-4
32. Goswami R, Gupta N, Ray D, Singh N, Tomar N. Pattern of 25-hydroxy vitamin D response at short (2 months) and long (1 year) interval after 8 weeks of oral supplementation with cholecalciferol in Asian Indians with chronic hypovitaminosis D. Br J Nutr 2008;6:1-4
33. Amizuka N, Kwan MY, Goltzman D, Ozawa H, White JH. Vitamin D3 differentially regulates parathyroid hormone/parathyroid hormone-related peptide receptor expression in bone and cartilage. J Clin Invest 1999;103:373-381
34. Sahota O, Mundey MK, San P, Godber IM, Lawson N, Hosking DJ. The relationship between vitamin D and parathyroid hormone: calcium homeostasis, bone turnover, and bone mineral density in postmenopausal women with established osteoporosis. Bone 2004;35:312-319
35. Schnitzler CM, Macphail AP, Shires R, Schnaid E, Mesquita JM, Robson HJ. Osteoporosis in African hemosiderosis: role of alcohol and iron. J Bone Miner Res 1994;9:1865-1873
36. Conte D, Caraceni MP, Duriez J, Mandelli C, Corghi E, Cesana M, Ortolani S, Bianchi PA. Bone involvement in primary hemochromatosis and alcoholic cirrhosis. Am J Gastroenterol 1989;84:1231-1234
37. Couttenye MM, D'Haese PC, Van Hoof VO Lemoniatou E, Goodman W, Verpooten GA, De Broe ME. Low serum levels of alkaline phosphatase of bone origin: a good marker of adynamic bone disease in haemodialysis patients. Nephrol Dial Transplant 1996;11:1065-1072
38. Van de Vyver FL, Visser WJ, D'Haese PC, De Broe ME. Iron overload and bone disease in chronic dialysis patients. Nephrol Dial Transplant 1990;5:781-787
39. de Vernejoul MC, Girot R, Gueris J, Cancela S, Bang J, Bielakoff C, Mautalen D, Goldberg, Miravet L. Calcium phosphate metabolism and bone disease in patients with homozygous thalassemia. J Clin Endocrinol Metab 1982;54:276-281
40. Prockop DJ. Role of iron in the synthesis of collagen in connective tissue. Fed Proc 1971;30:984-990
41. Tuderman L, Myllylä R, Kivirikko KI. Mechanism of the prolyl hydroxylase reaction 1. Role of co-substrates. Eur J Biochem 1977;80:341-348
42. Swarthout JT, D'Alonzo RC, Selvamurugan N, Partridge NC. Parathyroid hormone-dependent signaling pathways regulating genes in bone cells. Gene 2002;282:1-17
43. Holick MF. The influence of vitamin D on bone health across the life cycle. J Nutr 2005;135:2726S-2727S
44. Vieth R. Why the optimal requirement for Vitamin D3 is probably much higher than what is officially recommended for adults. J Steroid Biochem Mol Biol 2004;89-90:575-579
45. Holick MF. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr 2004;80(6 Suppl):1678S-1688S
46. Vieth R, Chan PC, MacFarlane GD. Efficacy and safety of vitamin D3 intake exceeding the lowest observed adverse effect level. Am J Clin Nutr 2001;73:288-294